Evidence that fasting hyperproinsulinemia after combined pancreas-kidney transplantation diminishes over time.
Larsen
J L
JL
Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198.
Stratta
R J
RJ
Miller
S A
SA
Hirst
K
K
Ozaki
C
C
Taylor
R J
RJ
Duckworth
W C
WC
D000328:Adult; D001120:Arginine / Q000008:administration & dosage; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D005215:Fasting / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D016030:Kidney Transplantation / Q000009:adverse effects / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000009:adverse effects / Q000502:physiology*; D011384:Proinsulin / Q000097:blood*; D013997:Time Factors
D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D005934:Glucagon; D011384:Proinsulin; D001120:Arginine